Investor Relations Home

Profile
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market.

The Company was incorporated in California in February 1989 as IRIS Medical Instruments, Inc. In November 1995, we changed our name to IRIDEX Corporation and reincorporated in Delaware. Investors and others should note that we announce material financial information to our investors using SEC filings, press releases, our investor relations website, public conference calls and webcasts.  We use these channels as well as social media to communicate with investors, customers and the public about our company, our products and other issues.  It is possible that the information we post on social media channels could be deemed to be material information.  We encourage investors, our customers, and others interested in our company to review the information we post on our Facebook page (www.facebook.com/IRIDEX) and Twitter feed (https://twitter.com/IRIDEX).
Stock Quote
IRIX (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.22
Change (%) Stock is Up 0.26 (3.27%)
Volume27,286
Data as of 07/02/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
05/28/15IRIDEX to Present at LD Micro Invitational
MOUNTAIN VIEW, Calif., May 28, 2015 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that Chief Operating Officer and Chief Financial Officer James H. Mackaness is scheduled to present at the LD Micro Invitational on Wednesday, June 3, 2015, at 9:00 am PT in Los Angeles. A live audio webcast of the presentation may be accessed on the Event Calendar of the Investors section of IRIDEX's website at www.iridex.com.  A replay of the webcast will be available shortly af... 
Printer Friendly Version
05/13/15IRIDEX to Present at UBS Global Healthcare Conference
MOUNTAIN VIEW, Calif., May 13, 2015 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that management is scheduled to present at the UBS Global Healthcare Conference on Tuesday, May 19, 2015, at 9:00 am ET in New York City. A live audio webcast of the presentation may be accessed on the Event Calendar of the Investors section of IRIDEX's website at www.iridex.com.  A replay of the webcast will be available shortly after the conclusion of the presentation and w... 
Printer Friendly Version
05/07/15IRIDEX Reports 2015 First Quarter Results
Record Q1 Revenues MOUNTAIN VIEW, Calif., May 7, 2015 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended April 4, 2015.  Revenues were $10.8 million in the first quarter of 2015, up 5% from $10.3 million in the 2014 first quarter and a record for first quarter revenues. Gross margin for the 2015 first quarter was 50.1%, up from 48.9% in the first quarter of the prior year. Operating income in the 2015 first quarte... 
Printer Friendly Version
04/30/15IRIDEX Announces First Quarter 2015 Conference Call and Release Date
MOUNTAIN VIEW, Calif., April 30, 2015 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that it will release its first quarter 2015 financial results after the market closes on Thursday, May 7, 2015.  In conjunction with the release, the Company will host a conference call with the investment community at 5:00 p.m. Eastern Time on Thursday, May 7, 2015 to discuss the results of the quarter and other business developments. Interested parties may access the live conf... 
Printer Friendly Version
Primary IR Contact
Jim Mackaness
Chief Financial Officer and Chief Operating Officer
Phone: 650-605-8716
E-mail: jmackaness@iridex.com


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.


logo aa0logo agslogo ascrslogo asrslogo esrs0logo euretina